Patent 4857533 Issued on August 15, 1989. Estimated Expiration Date: December 15, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
A method of treating a human or animal patient suffering from an autoimmune disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene or naltrexone may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
Other References
Chem. Abst. 100 (1984)-80084b-1
Chem. Abst. 108 (1988)-143338a
Rios et al., Eur. J. Pharm., 96:277-289 (1983)
Kayser et al., Proceedings of the Vth World Congress on Pain, pp. 72-79 (Elsevier Science Publishers 1988)
Hargreaves et al., Proceedings of the Vth World Congress on Pain, pp. 55-60 (Elsevier Science Publishers 1988)